1. Public Health Agency of Canada (2022, October 12). Modelling Opioid-Related Deaths during the COVID-19 Outbreak. Government of Canada. Updated 5 August 2022. Available online: https://www.canada.ca/en/health-canada/services/opioids/data-surveillance-research/modelling-opioid-overdose-deaths-covid-19.html.
2. (2022, October 12). Substance-Related Overdose and Mortality Surveillance Task Group (SOMS-TG) of the Special Advisory Committee (SAC) on the Epidemic of Opioid Overdoses—Public Health Agency of Canada. Apparent Opioid and Stimulant Toxicity Deaths: Surveillance of Opioid- and Stimulant-Related Harms in Canada January 2016 to March 2022. Government of Canada. Published September 2022. Available online: https://health-infobase.canada.ca/src/doc/SRHD/Update_Deaths_2022-09.pdf.
3. (2022, October 12). Substance-Related Overdose and Mortality Surveillance Task Group (SOMS-TG) of the Special Advisory Committee (SAC) on the Epidemic of Opioid Overdoses—Public Health Agency of Canada. Opioid and Stimulant Poisoning Hospitalizations: Surveillance of Opioid- and Stimulant-Related Harms in Canada January 2016 to March 2022. Government of Canada. Published September 2022. Available online: https://health-infobase.canada.ca/src/doc/SRHD/Update_Hospitalizations_2022-09.pdf.
4. The role of pharmacists in opioid stewardship: A scoping review;Gondora;Res. Soc. Adm. Pharm.,2022
5. Canadian Centre on Substance Use and Addiction (2022, October 14). Canadian Drug Summary: Prescription Opioids. Published July 2020. Available online: https://www.ccsa.ca/sites/default/files/2020-07/CCSA-Canadian-Drug-Summary-Prescription-Opioids-2020-en.pdf.